Merck KGaA and World Health Organization Conclude Partnership to Control Schistosomiasis in Africa

GENEVA & DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA (FWB:MRK) (GER:MRK) announced today the conclusion of a ten-year partnership with WHO to control schistosomiasis in African schoolchildren. For this purpose, Merck will provide for free 200 million tablets CesolĀ® 600 (active ingredient praziquantel) with a value of approximately USD 80 million.

Back to news